Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EVFM

Evofem

$4.04

0.54 (15.43%)

08:56
12/18/18
12/18
08:56
12/18/18
08:56
Recommendations
Evofem analyst commentary at Cantor Fitzgerald »

Evofem top-line data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Monday
GS

Goldman Sachs

$172.80

-3.07 (-1.75%)

, EVFM

Evofem

$3.50

-0.28 (-7.41%)

09:16
12/17/18
12/17
09:16
12/17/18
09:16
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Evofem (EVFM), up…

GS

Goldman Sachs

$172.80

-3.07 (-1.75%)

EVFM

Evofem

$3.50

-0.28 (-7.41%)

AXON

Axovant Sciences

$1.01

-0.12 (-10.62%)

BKS

Barnes & Noble

$6.49

-0.17 (-2.55%)

JACK

Jack in the Box

$80.22

-2.27 (-2.75%)

WFT

Weatherford

$0.43

-0.0258 (-5.61%)

BBY

Best Buy

$55.37

-0.56 (-1.00%)

THC

Tenet

$21.24

-2.25 (-9.58%)

CNC

Centene

$127.55

-5.3 (-3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 05

    Feb

  • 19

    Feb

EVFM

Evofem

$3.50

-0.28 (-7.41%)

08:15
12/17/18
12/17
08:15
12/17/18
08:15
Conference/Events
Evofem to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVFM

Evofem

$3.50

-0.28 (-7.41%)

06:05
12/17/18
12/17
06:05
12/17/18
06:05
Hot Stocks
Evofem AMPOWER Phase 3 trial meets primary endpoint »

Evofem announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
EVFM

Evofem

$3.45

0.01 (0.29%)

06:05
11/19/18
11/19
06:05
11/19/18
06:05
Conference/Events
Evofem management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 27

    Nov

Over a month ago
EVFM

Evofem

$3.44

(0.00%)

09:23
11/16/18
11/16
09:23
11/16/18
09:23
Conference/Events
Evofem management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 19

    Nov

  • 27

    Nov

EVFM

Evofem

$3.44

(0.00%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Evofem to hold a key opinion leader event »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

  • 19

    Nov

  • 27

    Nov

EVFM

Evofem

$3.44

0.06 (1.78%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Evofem to hold a key opinion leader event »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

  • 19

    Nov

  • 27

    Nov

EVFM

Evofem

$3.40

-0.38 (-10.05%)

09:16
11/08/18
11/08
09:16
11/08/18
09:16
Conference/Events
Evofem to hold a key opinion leader event »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 19

    Nov

  • 27

    Nov

EVFM

Evofem

$3.40

-0.38 (-10.05%)

06:51
11/08/18
11/08
06:51
11/08/18
06:51
Hot Stocks
Evofem completes Phase 3 clinical trial of Amphora »

Evofem Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 19

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.